GENE ONLINE|News &
A Novel Tool to Augment Checkpoint Inhibitor Cancer Therapy
Washington University School of Medicine researchers uncover the mechanism by which tumor-infiltrating myeloid cells create suppressive microenvironments. The findings provide a novel approach for augmenting the effects of checkpoint blockade therapies.
The suppressive tumor environment affects T cell responses by engaging immune checkpoint proteins such as PD-1.
GO Prime with only $1.49 now
LATEST
Absci Accelerates Breakthroughs in AI-Designed Drugs with AstraZeneca and Almirall Collaborations
2023-12-06
Saving Lives Through Communication, Heroic Faith Medical Science Showcasing Novel AI Auscultation Tool for Procedural Sedation Patients in PGA 77
2023-12-05
